Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803. Clin Cancer Res. 2009 Dec 01; 15(23):7322-9.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents
Camptothecin
Colonic Neoplasms
Disease-Free Survival
Female
Genes, ras
Humans
Male
Microsatellite Repeats
Middle Aged
Mutation
Oncogene Protein p21(ras)
Proportional Hazards Models
Treatment Outcome
authors with profiles
Robert James Mayer, M.D.
Monica Marie Bertagnolli, M.D.
Shuji Ogino, Ph.D., M.D.
Jeffrey A Meyerhardt, M.D.